Harbor Capital Advisors Inc. Has $7.08 Million Stake in Encompass Health Co. (NYSE:EHC)

Harbor Capital Advisors Inc. lifted its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 104.7% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 73,272 shares of the company's stock after buying an additional 37,473 shares during the quarter. Harbor Capital Advisors Inc. owned about 0.07% of Encompass Health worth $7,081,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of EHC. Commonwealth Equity Services LLC boosted its holdings in shares of Encompass Health by 1.3% during the second quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company's stock worth $845,000 after acquiring an additional 123 shares during the period. V Square Quantitative Management LLC boosted its holdings in Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock valued at $39,000 after purchasing an additional 140 shares during the period. O Shaughnessy Asset Management LLC boosted its stake in shares of Encompass Health by 3.9% in the first quarter. O Shaughnessy Asset Management LLC now owns 4,246 shares of the company's stock valued at $351,000 after buying an additional 160 shares during the period. Mount Yale Investment Advisors LLC grew its position in Encompass Health by 6.6% during the second quarter. Mount Yale Investment Advisors LLC now owns 2,749 shares of the company's stock worth $236,000 after buying an additional 170 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. increased its stake in Encompass Health by 58.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company's stock worth $46,000 after acquiring an additional 198 shares during the period. Institutional investors own 97.25% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently commented on EHC. Barclays raised their price target on Encompass Health from $109.00 to $116.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 29th. Leerink Partners began coverage on shares of Encompass Health in a research report on Wednesday, July 10th. They issued an "outperform" rating and a $100.00 target price for the company. UBS Group increased their price target on shares of Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research report on Wednesday, September 25th. Leerink Partnrs upgraded shares of Encompass Health to a "strong-buy" rating in a research report on Wednesday, July 10th. Finally, Truist Financial reaffirmed a "buy" rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a report on Wednesday. Nine analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $107.11.

Insider Buying and Selling at Encompass Health

In related news, CFO Douglas E. Coltharp sold 12,260 shares of Encompass Health stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total value of $1,058,528.40. Following the transaction, the chief financial officer now directly owns 136,227 shares of the company's stock, valued at $11,761,839.18. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 2.10% of the company's stock.

Encompass Health Price Performance

EHC traded down $0.55 on Friday, reaching $98.91. The stock had a trading volume of 771,681 shares, compared to its average volume of 669,557. The firm has a 50-day moving average of $94.47 and a 200-day moving average of $88.94. Encompass Health Co. has a fifty-two week low of $62.58 and a fifty-two week high of $102.36. The company has a market capitalization of $9.95 billion, a price-to-earnings ratio of 23.89, a price-to-earnings-growth ratio of 1.32 and a beta of 0.88. The company has a current ratio of 1.04, a quick ratio of 1.35 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same quarter last year, the business earned $0.86 EPS. The firm's quarterly revenue was up 11.9% on a year-over-year basis. As a group, sell-side analysts anticipate that Encompass Health Co. will post 4.28 EPS for the current year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.69%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health's payout ratio is presently 16.43%.

Encompass Health announced that its Board of Directors has authorized a share buyback program on Wednesday, July 24th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to purchase up to 5.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's management believes its stock is undervalued.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.